InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools

PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.

Cotiviti Client Conference Brings Together Health Plan Leaders to Strengthen Healthcare Ecosystem through Technology and Expertise

Optibrium Partners with FMC Corporation to Transform Agrochemical Discovery

Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline

FDB Expands its Medication Instructions to Include Translations of Hindi & Punjabi, 2 of the Fastest-Growing Languages in the US

https://www.prnewswire.com/news-releases/fdb-expands-its-medication-instructions-to-include-translations-of-hindi--punjabi-2-of-the-fastest-growing-languages-in-the-us-302141989.html?tc=eml_cleartime

Switchboard Health Announces $6.5M Series Seed Funding to Support New Partnerships with Health Plans and Value-Based Care Providers

Switchboard Health, creator of a high-value specialty care network and software platform, has secured $6.5 million in series seed funding.

Torbay Pharma strengthens leadership team to support North American growth strategy

Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). The company also reduced its standard turnaround time on WES and WGS to three weeks and continues to provide rapid testing with written reports in as few as five days.

Cresset® appoints new Chairman

Watson-Marlow introduces DriveSure® OEM pump solution at ACHEMA 2024

Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its recently launched DriveSure® panel mount pumps along with other products for life sciences companies at ACHEMA 2024 in Germany (June 10-14).

Guy’s and St Thomas’ NHS Foundation Trust Harnesses PhenoTips’ Genomic Health Record to Finalise 5 Year Strategy: Together We Care

Built on the strong visions and values of the Trust, Guy’s and St Thomas’ “Together We Care” strategy centers on three primary priorities, Patients, People, and Partnerships, aiming to bolster patient autonomy, invest in staff, and harness technologies in collaboration with commercial partners. Guy’s and St Thomas’ implementation of PhenoTips’ Genomic Health Record on the final year of their 2018-2023 strategy completes the ambitious 5-year plan by empowering patients to take an active role in the collection of their data, streamlining staff and provider workflows, and establishing a framework for deep integration between the partner technologies supporting the Trust.

Scientists have discovered a method to treat neurological diseases without heart-related side effects

The biotech startup Lactocore Group has reported unusual properties of a proprietary peptide, LCGA-17m16, aimed at treating neurological disorders without harming the heart that signal a potential paradigm shift in treating neurological disorders.

Cresset Targets Global Growth with New India HQ

Drug discovery specialist Cresset has announced a major milestone in its international growth with the launch of a new Indian HQ in Bangalore

Amerigo Scientific Adds Magnetic Silica Beads to Enlarge Its Nucleic Acid Extraction and Purification Toolbox

ResultsCX Named ‘Horizon 1 Disruptor’ in HFS Horizons: Customer Experience Service Providers, 2024 Report

Sharp Services announces expansion in Pennsylvania to facilitate growth in sterile injectable market

ECI Unveils Dynamic New Identity: A Fresh Vision for Global Leadership

ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company’s ongoing growth and dedication to innovation in the life sciences industry. This fundamental transformation includes a refreshed brand identity, focusing on a refined brand structure and elevated visual appeal.

YouScript Wins "Genomics Innovation Award" in 8th Annual MedTech Breakthrough Awards Program

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment, and growth management experience to his new role.

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

https://www.prnewswire.com/news-releases/dr-tim-garnett-former-chief-medical-officer-of-eli-lilly-joins-lindus-healths-advisory-board-302127131.html?tc=eml_cleartime